1. Home
  2. NOV vs IRTC Comparison

NOV vs IRTC Comparison

Compare NOV & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOV Inc.

NOV

NOV Inc.

HOLD

Current Price

$16.36

Market Cap

5.9B

Sector

Industrials

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$169.94

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOV
IRTC
Founded
1862
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.8B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
NOV
IRTC
Price
$16.36
$169.94
Analyst Decision
Hold
Strong Buy
Analyst Count
13
14
Target Price
$15.69
$203.93
AVG Volume (30 Days)
3.5M
454.2K
Earning Date
10-27-2025
10-30-2025
Dividend Yield
1.83%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
$8,775,000,000.00
$702,573,000.00
Revenue This Year
N/A
$27.20
Revenue Next Year
N/A
$16.89
P/E Ratio
$16.45
N/A
Revenue Growth
N/A
25.45
52 Week Low
$10.84
$84.17
52 Week High
$16.96
$212.00

Technical Indicators

Market Signals
Indicator
NOV
IRTC
Relative Strength Index (RSI) 61.98 38.34
Support Level $15.88 $166.76
Resistance Level $16.96 $187.98
Average True Range (ATR) 0.45 6.55
MACD 0.05 -1.41
Stochastic Oscillator 73.73 9.08

Price Performance

Historical Comparison
NOV
IRTC

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: